Copyright
©The Author(s) 2022.
World J Diabetes. Sep 15, 2022; 13(9): 717-728
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.717
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.717
Ref. | Type of study | Experimental groups | Source of probiotics | Dosage of probiotic | Duration of treatment |
Hartajanie et al[50], 2020 | Experimental: 24 male Sprague-Dawley rats at 8 wk and weighing 170-200 g | Diabetic group; Diabetic group + acarbose; Diabetic group + bitter melon; Diabetic group + fermented bitter melon | L. fermentum LLB3 was isolated from the bamboo shoot pickle | 1 × 107 CFU L. fermentum LLB3 | 4 wk |
Hu et al[35], 2019 | Experimental: 4-wk-old male Kunming mice (18 ± 2 g) were used | Normal control group; Diabetic group; Positive drug control group; Diabetic group + fructose 1 6-bisphosphatase (low dose); Diabetic group + 1-Deoxynojirimycin (middle dose); Diabetic group + 1-Deoxynojirimycin (high dose) | All probiotics were purchased from the Guangdong culture collection center | 5 × 104 CFU/mL of each activated strain (L. plantarum + L. fermentum, L. plantarum + L. mesenteroides, L. plantarum + S. cerevisiae, L. fermentum + L. mesenteroides, L. fermentum + S. cerevisiae, and L. mesenteroides + S. cerevisiae) | 4 wk |
Chaiyasut et al[51], 2018 | Experimental: male Wistar rats | Control group; Control group + L. fermentum; Control group + fermented H. erinaceus juice; Diabetic group; Diabetic group pretreatment and posttreatment treated with fermented H. erinaceus juice, L. fermentum, and insulin | L. fermentum HP3 was isolated from fermented Thai foods | L. fermentum HP3 in a concentration of 109 CFU/mL. L. fermentum HP3 was used with H. Erinaceus Juice | 12 wk |
Guilbaud et al[52], 2020 | Experimental: 30 mice with 6 wk of age | Wild-type group;Wild-type group + L. fermentum;Diabetic group;Diabetic group + L. fermentum | Isolated from a fecal sample of one-year-old healthyEstonian child | L. fermentum ME-3 in a concentration of 1010 CFU per 400 μL H2O | 12 wk |
Archer et al[48], 2021 | Experimental: 40 female Wistar rats | Control group; Diabetic group + high-fat diet; Diabetic group + high-fat diet + L. fermentum. MCC2759; Diabetic group + high-fat diet + L. fermentum. MCC2760 | Isolated from fecal (L. fermentum. MCC2759) and from curd (L. fermentum. MCC2760) | Both isolated probiotics were offered in a concentration of 1 × 109 CFU/mL | 4 wk |
Ai et al[31], 2021 | Experimental: 160 Male C57BL/6J mice with 6 wk of age | Control group; Diabetic group + high-fat diet; Diabetic group + defatted rice bran unfermented extracts; Diabetic group + pioglitazone; Diabetic group + high-dose of defatted rice bran fermentation extracts; Diabetic group + low-dose of defatted rice bran fermentation extracts | Isolated from Chinese rice noodle wastewater | The study evaluated the role of L. fermentum MF423. Dose of 100 μg/mL of defatted rice bran unfermented extracts | 8 wk |
Yadav et al[54], 2018 | Experimental: 70 male Wistar rats with 8 ws old | Normal control group; Diabetic control group; Diabetic + normal diet supplemented with milk; Diabetic + L. rhamnosus MTCC5957; Diabetic + L. rhamnosus MTCC5897; Diabetic + L. fermentum MTCC 5898; Diabetic + L.rhamnosus 5957 and 5958 and L. fermentum MTCC 5898 | The probiotics L. rhamnosus MTCC: 5957 and L. rhamnosus MTCC: 5897 were isolated from household curds. The probiotic L. fermentum MTCC: 5898 was isolated from the feces of breastfed human infants | All probiotic strains were offered in a dosage of 1 × 109 CFU | 6 wk |
Yousaf et al[55], 2016 | Experimental: female mice of 6-8 wk, with an initial body weight of 21-23 g | Normal healthy mice; Diabetic mice; Diabetic mice + Momordica charanti; Diabetic mice + Eugenia Jambolana; Diabetic mice + L. Fermentum; Diabetic mice + L. Fermentum + Momordicacharanti + Eugenia Jambolana; Diabetic mice + Glucophage | L. fermentum fruit extracts of Eugenia Jambolana and Momordica charantia were isolated from local yogurt samples (Lahore, Pakistan) | Momordica charantia 200 mg/kg, and Eugenia Jambolana 100 mg/kg. The authors did not inform the concentration of L. fermentum (Gene Bank Accession KJ754019) | 3 wk |
Balakumar et at[49], 2018 | Experimental: adult male C57BL/6J mice (age 8-10 wk) | Normal pellet diet; High-fat diet; High-fat diet + L. rhamnosus; High-fat diet + L. plantarum MTCC5690; High-fat diet + L. fermentum MTCC5689; High-fat diet + metformim; High-fat diet + vildagliptin | Isolated from Indian gut (Karnal, India) | Lactobacillus MTCC 5690 and MTCC 5689 in a concentration of 1.5 × 109 colonies/mouse/d | 24 wk |
Babadi et al[30], 2018 | Clinical: primigravid women aged between 18 and 40 years, between the 24th and 28th week of gestation, diagnosed with gestational diabetes mellitus | Placebo group; Probiotic group | Probiotic supplements were produced by LactoCare®, Zisttakhmir Company (Tehran, Iran) | Probiotic capsule containing Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum and L. fermentum in a dosage of 2 × 109 CFU/g | 6 wk |
- Citation: Lacerda DC, Trindade da Costa PC, Pontes PB, Carneiro dos Santos LA, Cruz Neto JPR, Silva Luis CC, de Sousa Brito VP, de Brito Alves JL. Potential role of Limosilactobacillus fermentum as a probiotic with anti-diabetic properties: A review. World J Diabetes 2022; 13(9): 717-728
- URL: https://www.wjgnet.com/1948-9358/full/v13/i9/717.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i9.717